Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

Influenza is a major public health concern causing millions of hospitalizations every year. The current vaccines need annual updating based on prediction of likely strains in the upcoming season. However, mismatches between vaccines and the actual circulating viruses can occur, reducing vaccine effe...

Full description

Bibliographic Details
Main Authors:	Abenaya Muralidharan, Caroline Gravel, Greg Harris, Anwar M. Hashem, Wanyue Zhang, David Safronetz, Gary Van Domselaar, Florian Krammer, Simon Sauve, Michael Rosu-Myles, Lisheng Wang, Wangxue Chen, Xuguang Li
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-11-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	influenza universal antibody uni-1 antibody-dependent cellular cytotoxicity (adcc) cross-protection
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2083428

Similar Items

Influenza and Antibody-Dependent Cellular Cytotoxicity
by: Tarra A. Von Holle, et al.
Published: (2019-06-01)

Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
by: Rongyuan Gao, et al.
Published: (2020-03-01)

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus
by: Fan Yang, et al.
Published: (2020-01-01)

ADCC: An underappreciated correlate of cross-protection against influenza?
by: Rory D. de Vries, et al.
Published: (2023-02-01)

NK cell-based autologous immune enhancement therapy (AIET) for cancer (Invited Review)
by: Terunuma H, et al.
Published: (2013-04-01)

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors
by: Susanne Wingert, et al.
Published: (2021-01-01)

Monoclonal Antibodies in Cancer Therapy
by: David Zahavi, et al.
Published: (2020-07-01)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
by: Marsha S. Russell, et al.
Published: (2021-09-01)

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
by: George K. Lewis, et al.
Published: (2019-05-01)

The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine
by: Sinthujan Jegaskanda
Published: (2018-05-01)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
by: Carolyn M. Boudreau, et al.
Published: (2019-03-01)

Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies
by: Jamie Valeich, et al.
Published: (2020-09-01)

Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms
by: Kashyap R. Patel, et al.
Published: (2019-02-01)

CD47-SIRPα Controls ADCC Killing of Primary T Cells by PMN Through a Combination of Trogocytosis and NADPH Oxidase Activation
by: Françoise Gondois-Rey, et al.
Published: (2022-06-01)

Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
by: Sinthujan Jegaskanda, et al.
Published: (2017-06-01)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
by: Kimone Leigh Fisher, et al.
Published: (2020-07-01)

A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics
by: Haiyan Sun, et al.
Published: (2023-05-01)

ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
by: Kawaljit Kaur, et al.
Published: (2021-01-01)

Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids
by: Nicky A. Beelen, et al.
Published: (2023-07-01)

Improving Immunotherapy Through Glycodesign
by: Matthew J. Buettner, et al.
Published: (2018-11-01)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
by: Simone I. Richardson, et al.
Published: (2021-09-01)

Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
by: Ming Yang, et al.
Published: (2023-03-01)

Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
by: Marta Lustig, et al.
Published: (2023-06-01)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
by: Bruce D. Wines, et al.
Published: (2021-10-01)

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
by: Laura E Doepker, et al.
Published: (2021-01-01)

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
by: Kwok Hang Fai, et al.
Published: (2011-12-01)

Characterization of zolbetuximab in pancreatic cancer models
by: Ӧzlem Türeci, et al.
Published: (2019-01-01)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
by: Sonia Jangra, et al.
Published: (2022-11-01)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
by: Franck P. Dupuy, et al.
Published: (2019-12-01)

Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
by: Ryan Yucha, et al.
Published: (2023-10-01)

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ
by: Kawaljit Kaur, et al.
Published: (2023-01-01)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
by: Emilie Decaup, et al.
Published: (2019-08-01)

Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
by: Caroline Gravel, et al.
Published: (2021-11-01)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01)

Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
by: Lorena Vigón, et al.
Published: (2021-09-01)

Exploiting NK Cell Surveillance Pathways for Cancer Therapy
by: Alexander David Barrow, et al.
Published: (2019-01-01)

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors
by: Andrew R. Crowley, et al.
Published: (2021-10-01)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
by: Patricia Gogesch, et al.
Published: (2021-08-01)

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
by: Jennifer L. Schwedler, et al.
Published: (2024-12-01)